Prudent Corporate Advisory Services Ltd

Prudent Corp. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Prudent Corporate Advisory Services Ltd

₹ 2,688 -0.12%
21 May - close price
prudentcorporate.com BSE: 543527 NSE: PRUDENT
About

Incorporated in 2003, Prudent Corporate Advisory Services Limited provides retail wealth management services. The company offers Mutual Fund products, Life and General Insurance solutions, Stock Broking services, SIP with Insurance, Gold Accumulation Plan, Asset Allocation, and Trading platforms.[1]

Key Points

Product Offerings[1]
A) Mutual Funds: Open-source distribution of mutual fund products.
B) Insurance: Includes life insurance (term, par, non-par, annuity plans) and general insurance (primarily health insurance).
C) Stockbroking: Services for retail customers to trade equities, derivatives, and currency.
D) Other Financial Products: PMS, AIF, P2P products, bonds, fixed deposits, smallcase, unlisted securities, LAS (Loan Against Securities), and sovereign gold bonds.

Website BSE NSE
  • Market Cap ₹ 11,104 Cr.
  • Current Price ₹ 2,688
  • High / Low ₹ 3,098 / 1,955
  • Stock P/E 50.0
  • Book Value ₹ 213
  • Dividend Yield 0.09 %
  • ROCE 37.5 %
  • ROE 28.6 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 37.4% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 31.5%

Cons

  • Stock is trading at 12.6 times its book value
  • Promoter holding has decreased over last 3 years: -3.13%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Financial Services Financial Services Capital Markets Financial Products Distributor

Part of BSE Financial Services Nifty Microcap 250 Nifty Total Market BSE 1000 Nifty Smallcap 500

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
177 165 190 210 240 249 286 285 283 294 320 343 361
118 126 147 160 179 190 217 219 214 226 248 265 268
Operating Profit 58 39 43 50 61 59 69 66 69 67 72 78 93
OPM % 33% 24% 23% 24% 25% 24% 24% 23% 24% 23% 23% 23% 26%
3 5 4 5 6 7 8 7 8 10 8 10 -5
Interest 1 0 0 0 1 0 1 1 1 1 1 2 2
Depreciation 6 6 6 6 6 6 7 7 7 7 8 8 8
Profit before tax 55 38 41 48 60 59 69 64 69 70 72 78 79
Tax % 25% 25% 25% 25% 25% 25% 26% 25% 25% 26% 26% 26% 25%
41 28 30 36 45 44 52 48 52 52 54 58 59
EPS in Rs 9.96 6.78 7.35 8.62 10.76 10.67 12.44 11.64 12.50 12.51 12.93 13.92 14.28
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
225 236 295 458 617 823 1,133 1,317
185 188 225 335 436 612 841 1,007
Operating Profit 40 48 70 123 181 211 292 310
OPM % 18% 20% 24% 27% 29% 26% 26% 24%
-1 0 0 0 2 1 0 23
Interest 3 3 2 3 2 2 2 5
Depreciation 8 8 8 13 24 25 28 31
Profit before tax 29 37 61 107 157 186 262 298
Tax % 27% 26% 25% 25% 26% 25% 25% 25%
21 28 45 80 117 139 196 222
EPS in Rs 203.37 269.45 438.27 19.40 28.18 33.51 47.25 53.63
Dividend Payout % 22% 1% 1% 5% 5% 6% 5% 7%
Compounded Sales Growth
10 Years: %
5 Years: 35%
3 Years: 29%
TTM: 16%
Compounded Profit Growth
10 Years: %
5 Years: 37%
3 Years: 24%
TTM: 14%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 46%
1 Year: 3%
Return on Equity
10 Years: %
5 Years: 33%
3 Years: 32%
Last Year: 29%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 1 1 1 21 21 21 21 21
Reserves 82 111 157 217 329 461 647 862
30 17 13 13 17 20 31 34
80 66 115 148 152 255 245 308
Total Liabilities 193 196 285 399 519 757 944 1,224
24 27 26 174 164 153 162 257
CWIP 0 0 0 0 0 0 0 1
Investments 7 6 21 39 143 246 365 580
162 162 238 185 212 357 416 386
Total Assets 193 196 285 399 519 757 944 1,224

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
13 50 58 93 120 150 161 217
13 -2 -28 -163 -106 -139 -142 -200
-9 -22 -11 -10 -12 -14 -18 -22
Net Cash Flow 16 26 19 -81 3 -4 0 -5
Free Cash Flow 8 47 56 91 118 145 143 209
CFO/OP 63% 127% 103% 96% 83% 95% 77% 93%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 126 61 85 75 61 63 47 50
Inventory Days
Days Payable
Cash Conversion Cycle 126 61 85 75 61 63 47 50
Working Capital Days -10 -8 -25 -16 -3 -10 0 -2
ROCE % 33% 41% 52% 51% 43% 44% 37%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Mutual Fund Assets Under Management (AUM)
₹ Crore

Log in to view insights

Please log in to see hidden values.

Login
Number of Mutual Fund Distributors (MFDs)
Number
Insurance Premium
₹ Crore
Market Share in SIP Flows
%
Number of Locations (Branches)
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
58.43% 58.43% 58.43% 58.43% 58.43% 55.71% 55.71% 55.71% 55.31% 55.31% 55.31% 55.31%
1.42% 3.81% 3.77% 12.11% 12.91% 14.63% 14.77% 17.63% 17.47% 16.85% 16.32% 14.89%
9.23% 15.67% 15.75% 15.69% 22.28% 23.92% 23.63% 20.71% 20.76% 21.47% 22.13% 23.58%
30.92% 22.09% 22.05% 13.77% 6.38% 5.74% 5.88% 5.95% 6.46% 6.36% 6.23% 6.21%
No. of Shareholders 19,75920,48522,65921,84620,48123,47029,59831,75432,67432,00230,93832,373

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls